Delivra Health Brands Inc · TSXV:DHB
Delivra Health Brands — Investor Presentation (2024)
23 slides from Delivra Health Brands's investor presentation, Nov 26, 2024
Slide 1: Building a community of wellness, naturally.
Building a community of wellness, naturally.
Slide 2: Disclaimer
Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered DISCLAIMER reasonable by management, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward- looking statements involve known
Slide 3: Who We Are
WHO WE ARE A GLOBAL PORTFOLIO OF BRANDS A natural, clinically proven, transdermal cream for fast-acting relief of chronic pain such as osteoarthritis, and rheumatoid Helping people take control of their arthritis pain. health with alternative wellness solutions is what energizes the Delivra Health B
Slide 4: Delivra Health Brands: Rebranding for Success
DELIVRA HEALTH BRANDS REBRANDING FOR SUCCESS Delivra Health Brands has delivered on commitments! 2020 2021 2022 2023 2024 New Leadership Asset Light (CMO $8.2M Debt New Launches & $7.2M Debt $4.9M Debt Strategic Review Strategy) Revenue +2% Expansions Revenue +20% Revenue +26% YOY $21+M Debt $9.1M D
Slide 5: Strategy Overview
STRATEGY OVERVIEW PEOPLE/ SUPPORT Right people, right areas, right time MARKETING & BRAND BUILDING Digital, E-commerce, Integrated Campaigns, Social, Influencers, Insights INVESTMENT- ALLOCATION OF FUNDS Listing fees, programs, ads, promotions, shelf space INVESTOR RELATIONS/ PUBLIC RELATIONS IR Fir
Slide 6: A Health and Wellness CPG Leader: Vision and Mission
A HEALTH AND WELLNESS CPG LEADER VISION We are building a community of wellness, naturally. MISSION We are pioneering the alternative wellness space with innovative products that bring relief to everyday health issues and enhance quality of life. ● Health & wellness CPG leader, leveraging OTC brand
Slide 7: Investment Highlights
INVESTMENT HIGHLIGHTS POSITIONED FOR ACCELERATED GROWTH PEOPLE: OUR TEAM ● Experienced CPG leadership team with proven track record ● Proprietary delivery technologies & uniquely differentiated products PRODUCT PORTFOLIO & INNOVATION ● Large portfolio with OTC/Infused ● Sizable product innovation pi
Slide 8: Effective & Efficient CPG Business Model
EFFECTIVE & EFFICIENT CPG BUSINESS MODEL: SCALABLE HEALTH & WELLNESS A global company, with highly developed brands, operating a lean asset model to generate significant future value. IN-HOUSE OUTSOURCED REVENUE GENERATION Own the IP & product innovation Asset light model based on IP ownership New p
Slide 9: Our Brands, Products, and Solutions
OUR BRANDS, PRODUCTS, AND SOLUTIONS SLEEP SOLUTIONS CHRONIC PAIN RELIEF INFUSED RELIEF A leading sleep solution Market leader in natural pain relief topicals First medically launched infused topical cream “Shush Your Mind.” “Quiets Chronic Pain.” OTC product with three active ingredients Internally
Slide 10: Dream Water
DREAM WATER® SHUSH YOUR MIND What makes Dream Water® different? Dream Water® is a fast-acting sleep solution containing three active ingredients to help with occasional sleeplessness. Whether you're traveling, preparing for a big day, or just need extra rest, Dream Water’s proprietary formula is rea
Slide 11: Consumers Love
Consumers LOVE Building a community of wellness, naturally.
Slide 12: Dream Water: Over 35+ million units sold
DREAM WATER® Over 35+ million units sold GLOBAL DISTRIBUTION PARTNERS Our track record We built our business in Grocery, and C- Store, and now we are expanding into mass! Available in 30,000+ touchpoints across the globe. Dream Water is the #1 selling sleep shot. Building a community of wellness, na
Slide 13: LivRelief
LivRelief QUIETS CHRONIC PAIN What makes LivRelief different? LivRelief topical creams are made using naturally sourced ingredients and built on the backbone of the clinically proven Delivra delivery system to provide a transdermal solution to pain. Our creams are fast acting, targeted and provide t
Slide 14: LivRelief: Delivra Transdermal Delivery System
LivRelief DELIVRA TRANSDERMAL DELIVERY SYSTEM “The Delivra Transdermal Delivery System delivers active ingredients right through the skin’s pores to the source of pain and healing.” “If you could deliver medication with a cream – and it was more effective than taking a pill –which one would you choo
Slide 15: Our Customers Love
Our customers LOVE Building a community of wellness, naturally.
Slide 16: LivRelief: Over 2.5 million units sold
LivRelief Over 2.5 million units sold INTERNATIONAL DISTRIBUTION PARTNERS Expanding into new markets We’ve helped millions of customers find relief in Canada, and now we’re expanding internationally! Building a community of wellness, naturally.
Slide 17: LivRelief Infused
LivRelief Infused Licensed for sale in Canada through a key licensed provider What makes LivRelief Infused different? LivRelief Infused Transdermal Creams contain our proprietary delivery system to penetrate deep through the skin and tissue layers delivering a range of CBD, THC, and other actives to
Slide 18: Global Market Opportunity to 2032
GLOBAL MARKET OPPORTUNITY TO 2032 There is significant market opportunity globally for Delivra Health Brands products and brands. The sleep aid market is The topical pain relief expected to show strong market will continue to growth grow The global topical pain relief The global over-the-counter mar
Slide 19: Year-over-Year Financial Performance as per Reported MD&A
YEAR-OVER-YEAR FINANCIAL PERFORMANCE AS PER REPORTED MD&A Select financial information June 2024 $ June 2023 $ June 2022 $ June 2021 $ June 2020 $ Fiscal 2024 vs. Fiscal 2023: (Expressed in thousands of Canadian dollars, except • Improved net revenue by 26% growth share and per share year over year
Slide 20: Market Information
MARKET INFORMATION Share structure as of December 2023 Share ownership As of Feb 26, 2024 $ Management & strategic investor 116M 37% Share price 0.04 Public float 197M 63% Total shares outstanding 313M 100% Market capitalization 12.5M Options 14M 52-Week low 0.01 Warrants 97M 52-Week high 0.04 Fully
Slide 21: Our Team
OUR TEAM LEADERSHIP TEAM GORD DAVEY Mr. Davey is a senior executive with more than 25 years experience in the consumer- packaged President & Chief Executive Officer goods industry. He has held senior level positions at organizations such as Coca-Cola, Red Bull and Puratos. He has successfully led te
Slide 22: Our Team: Board of Directors
OUR TEAM BOARD OF DIRECTORS Mr. Holler is President and CEO of Ponderosa Capital Inc. and is actively involved in the biopharma and FRANK HOLLER technology industries. He previously served as President & CEO of Xenon Pharmaceuticals from 1999 to 2003 Executive Chairman and as Chairman & CEO at BC Ad
Slide 23: Building a community of wellness, naturally.
For additional information, please contact: INVESTOR RELATIONS Phone: +1 (877) 915 7934 Email: [email protected] Web: www.delivrahealth.com Building a community of wellness, naturally.